David Jones
Source: https://pure.qub.ac.uk/en/persons/david-jones/ Parent: https://www.qub.ac.uk/courses/undergraduate/pharmaceutical-biotechnology-sandwich-bsc-b213/
David Jones
Professor
- Professor, School of Pharmacy
-
Phone+44 (0)28 9097 2011
-
EmailD.Jones@qub.ac.uk
-
Room 01.063 - Pharmacy & MCI
United Kingdom
Accepting PhD Students
PhD projects
Biocompatible implants for improved pain control post-surgery\ \ Mucoadhesive platforms for enhanced drug delivery to the oral cavity\ \ Production methods for mucoadhesive microspheres based on fluid dynamics
1990 …Projects 2002: 1Research output 2002: 7Research output 2003: 9Projects 2004: 2Research output 2004: 6Projects 2005: 1Research output 2005: 9Projects 2006: 1Research output 2006: 22Projects 2007: 2Research output 2007: 15Projects 2008: 2Research output 2008: 12Projects 2009: 1Research output 2009: 14Projects 2010: 1Research output 2010: 16Projects 2011: 1Research output 2011: 11Projects 2012: 1Research output 2012: 20Research output 2013: 24Research output 2014: 30Projects 2015: 1Research output 2015: 21Research output 2016: 17Projects 2017: 3Research output 2017: 11Projects 2018: 1Research output 2018: 15Research output 2019: 26Research output 2020: 12Research output 2021: 13Research output 2022: 12Projects 2023: 1Research output 2023: 4Research output 2024: 7Research output 2025: 10Research output 2026: 12026
Research activity per year
Personal profile
Fingerprint
Dive into the research topics where David Jones is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
-
4 Similar Profiles
-
Drug Pharmacology, Toxicology and Pharmaceutical Science
- Polymer Pharmacology, Toxicology and Pharmaceutical Science
- Biomaterial Material Science
- Drug Release Pharmacology, Toxicology and Pharmaceutical Science
- Antiinfective Agent Pharmacology, Toxicology and Pharmaceutical Science
- Drug Delivery Pharmacology, Toxicology and Pharmaceutical Science
- Amorphous Solid Dispersion Pharmacology, Toxicology and Pharmaceutical Science
- Surface Material Science
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or Select a country/territory from the list\
Dive into details
Select a country/territory to view shared publications and projects
Close
Projects
- 5 Finished
-
6 Active
-
R1874PMY: MICA: EnLAmB - Enabling global access to affordable generic liposomal amphotericin B injectable formulations via advanced manufacturing technology
Tian, J. (PI), Al-Jamal, W. (CoI), Andrews, G. (CoI) & Jones, D. (CoI)
10/03/2023 → …
Project: Research
- Amphotericin B Lipid Complex
- Phospholipid
- Phase Separation
- Amphotericin B
- Felodipine
-
S2412PMY: KTP/Devenish Nutrition Ltd
Andrews, G. (CoI), Jones, D. (CoI), Li, S. (CoI) & Tian, J. (CoI)
01/05/2017 → …
Project: ktp - ### S2578PMY: Fusion/ Solvotrin Therapeutics
Jones, D. (PI)
01/08/2010 → …
Project: ktp - ### R3110PMY: Hot melt extrusion of stable drug solutions in polymer matrices as dosage forms
Jones, D. (PI)
01/08/2008 → …
Project: Research - ### S2269PMY: KTP/ TG Eakin Ltd
Jones, D. (PI)
01/08/2007 → …
Project: ktp
Research output
- 111 Article
- 34 Paper
- 27 Poster
- 9 Chapter
-
15 More
- 4 Meeting abstract
- 3 Book
- 3 Chapter (peer-reviewed)
- 3 Editorial
- 2 Abstract
- 2 Other contribution to conference
- 2 Review article
- 1 Conference contribution
- 1 Other chapter contribution
- 1 Comment/debate
-
The influence of drug loading on dissolution behaviours and stability of surfactant-containing amorphous solid dispersions
Liu, D., Jones, D. S. & Andrews, G. P., 12 Feb 2026, (Early online date) In: International Journal of Pharmaceutics. p. 126673 46 p., 126673.
Research output: Contribution to journal › Article › peer-review
Open Access
File
- Surfactant
- Amorphous Solid Dispersion
- Heart Atrium Septum Defect
- Amorphous Material
- Surface Active Agent
2 Downloads (Pure) - ### Development of antibacterial coatings for endotracheal tubes with enhanced antibacterial release properties through combined antibiotic loading
Wylie, M. P., Li, J., Murphy, G., Ross, J., Burns, J., Jones, D. S. & McCoy, C. P., 14 Sept 2025, (Early online date) In: Journal of Pharmacy and Pharmacology. 10 p., rgaf078.
Research output: Contribution to journal › Article › peer-review
Open Access
File
- Antiinfective Agent
- Antimicrobial Agent
- Benzalkonium Chloride
- Levofloxacin
- Drug Release
15 Downloads (Pure) - ### Development of media simulating the properties of human peritoneal fluid and verification of its bio-relevance
Abdelquader, M. M., Li, S., Andrews, G. P. & Jones, D. S., Dec 2025, In: European Journal of Pharmaceutics and Biopharmaceutics. 217, 11 p., 114908.
Research output: Contribution to journal › Article › peer-review
Open Access
File
- Peritoneum Tumor
- Surgical Wound
4 Downloads (Pure) - ### Development of superhydrophobic poly(vinyl chloride) materials with enhanced antibacterial properties for the prevention of ventilator-associated pneumonia
Li, J., Ross, J., Irwin, N. J., Carson, L., Jones, D. S., McCoy, C. P. & Wylie, M. P., 30 Jun 2025, In: Applied Surface Science. 695, 9 p., 162904.
Research output: Contribution to journal › Article › peer-review
Open Access
File
- Ventilator Associated Pneumonia
- Superhydrophobic
- Antiinfective Agent
- Polyvinylchloride
- Surface (Surface Science)
5 Citations (Scopus)
60 Downloads (Pure) - ### Fatty acid-containing p(HEMA) hydrogels; a promising coating platform to reduce encrustation on urinary catheters
Jones, D. S., Andrews, G. P., Hamill, T. & Gilmore, B. F., 17 Feb 2025, In: Polymers. 17, 4, 17 p., 518.
Research output: Contribution to journal › Article › peer-review
Open Access
File
- Fatty Acid
- 2 Hydroxyethyl Methacrylate
- Fatty Acid Salts
- Contact Angle
- Hydrogel
2 Citations (Scopus)
34 Downloads (Pure)
Prizes
Jones, D. (Recipient), 06 Sept 2023
Prize: Prize (including medals and awards) - ### British Pharmaceutical Conference Science Medal (Top Pharmaceutical Scientist under the age of 35 years)
Jones, D. (Recipient), 1997
Prize: Prize (including medals and awards) - ### Chapman Medal of the Institute of Materials, Minerals and Mining
Jones, D. (Recipient), 2024
Prize: Prize (including medals and awards)
- Biomaterial
- Biomedical Materials
-
Eli Lilly Award for Pharmaceutical Excellence
Jones, D. (Recipient), 1997
Prize: Prize (including medals and awards) - ### Griffith Medal of the Institute of Materials, Minerals and Mining
Jones, D. (Recipient), 01 Sept 2019
Prize: Prize (including medals and awards)
- Materials Science
Activities
- 8 KTP & Consultancy in kind
- 6 Membership of peer review panel or committee
- 5 Editorial activity
- 3 Invited talk
-
10 More
- 3 Research and Teaching at External Organisation
- 2 Other examination
- 2 Membership of external research organisation
- 2 Membership of public/government advisory/policy group or panel
- 1 Participation in conference
- 1 Participation in Festival/Exhibition
- 1 Participation in workshop, seminar, course
- 1 Contribution to the work of national or international committees and working groups
- 1 PGT external examination
-
EnLAmB – An advanced manufacturing technology to produce generic liposomal amphotericin b formulations
Kenaan, H. (Presenter), Duncan, R. (Advisor), Jones, D. (Advisor), Al-Jamal, W. (Advisor), Andrews, G. (Advisor) & Tian, J. (Invited speaker)
12 Nov 2024 → 13 Dec 2024
Activity: Talk or presentation types › Invited talk - ### Academy of Medical Sciences (External organisation)
Jones, D. (Advisor)
Jun 2023 → …
Activity: Membership types › Membership of peer review panel or committee - ### Royal Irish Academy (External organisation)
Jones, D. (Advisor)
May 2023 → …
Activity: Membership types › Membership of peer review panel or committee - ### Royal Irish Academy (External organisation)
Jones, D. (Advisor)
May 2023 → …
Activity: Membership types › Membership of peer review panel or committee - ### Mentor on the SUSTAIN scheme for young medical scientists
Jones, D. (Recipient)
Jan 2023 → …
Activity: Other activity types › Other
Impacts
Jones, D. (Participant)
Impact: Quality of Life Impact, Economic Impact, Health Impact